Скачать или смотреть Compounded GLP-1 Medications: What’s Changing and Why? | GoodRx

Starting in 2022, manufacturers didn’t have enough supply of injectable GLP-1 (glucagon-like peptide-1) medications like semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) in order to keep pace with demand. In late 2024, the FDA indicated that the tirzepatide injection shortage was over, and in early 2025, the semaglutide injection shortage was also resolved. In this video, learn what this means for the availability of compounded GLP-1 medications, according to Stacia Woodcock, PharmD, Pharmacy Editor at GoodRx.

Learn more: https://goodrx.co/GLP1Switch

Go to https://goodrx.co/health for the answers you need from doctors, pharmacists, and journalists you can trust.

Follow Us On Social:
TikTok - https://goodrx.co/TikTok
Instagram - https://goodrx.co/instagram
Facebook - https://goodrx.co/Facebook
X - https://x.com/GoodRx

#glp1 #glp1medication #semaglutide